Related Experiment Videos
Immunoactive peptides, FK 156 and FK 565. IV. Activation of mouse macrophages
Abstract:
We investigated the effects of the immunoactive peptides, FK 156 and FK 565, on functions of mouse macrophages. FK 156 and FK 565 given parenterally or orally to mice enhanced spreading of peritoneal macrophages, phagocytosis of latex particles and intracellular killing of bacteria by peritoneal macrophages. FK 156 and FK 565 also enhanced the production of superoxide anion and lysosomal enzyme activities of macrophages. The peptides also activated mouse spleen macrophages, and the kinetics of this activation differed from that of the peritoneal macrophages. In addition, both drugs directly enhanced the production of superoxide anion by mouse peritoneal macrophages treated in vitro and enhanced the functions of peritoneal macrophages of athymic nude mice. Both these phenomena suggest that direct activation might be one of the mechanisms of macrophage activation by the peptides.
Insights
The immunoactive peptides FK 156 and FK 565 enhance macrophage functions, including phagocytosis and bacterial killing. These peptides directly activate macrophages, suggesting a potential therapeutic mechanism for immune system modulation.
Area of Science:
- Immunology
- Pharmacology
- Cell Biology
Background:
- Macrophages are critical immune cells involved in pathogen clearance and immune regulation.
- Immunoactive peptides can modulate immune cell functions.
- Understanding the mechanisms of macrophage activation is key to developing immunotherapies.
Purpose of the Study:
- To investigate the effects of immunoactive peptides FK 156 and FK 565 on mouse macrophage functions.
- To determine if these peptides directly activate macrophages.
- To explore potential therapeutic applications of FK 156 and FK 565.
Main Methods:
- Administration of FK 156 and FK 565 to mice (parenteral and oral).
- Assessment of macrophage functions: spreading, phagocytosis, intracellular killing, superoxide anion production, and lysosomal enzyme activity.
- In vitro treatment of macrophages with peptides.
- Evaluation of macrophages from athymic nude mice.
Main Results:
- FK 156 and FK 565 enhanced peritoneal macrophage spreading, phagocytosis, and bacterial killing.
- Peptide administration increased superoxide anion production and lysosomal enzyme activity in macrophages.
- Both spleen and peritoneal macrophages were activated, with differing kinetics.
- Direct activation of macrophages in vitro and in athymic nude mice was observed.
Conclusions:
- FK 156 and FK 565 significantly enhance multiple functions of mouse macrophages.
- Direct activation of macrophages appears to be a key mechanism of action for these peptides.
- These findings suggest FK 156 and FK 565 as potential agents for immunomodulation.